SoFi Technologies (NASDAQ:SOFI), like other speculative growth stocks, has rallied thanks to the latest signs that inflation is easing. In recent trading days, SOFI stock has climbed back out of “penny stock territory,” (under $5 per share). Shares could also continue to inch higher over the next two weeks or so, ahead of the fintech
Stock Market
Stocks of electric vehicle (EV) makers were battered in 2022. Chip shortages, supply chain bottlenecks, Covid-19-led disruptions in China and macro headwinds took a toll on the industry. Yet, the long-term prospects for EV companies remain attractive due to growing consumer interest, favorable regulation and tax credits to boost EV adoption. Strategic research provider BloombergNEF
Now more than ever, it seems like investors are glued to the financial news. Not just because it’s interesting, but because we’ve been in a tough bear market for the past 12 months. It’s got investors wondering what’s happening today and what are the hot stocks for tomorrow. With earnings season underway, focus on the
Invariably, with the Federal Reserve forced into the unenviable task of taking away the monetary punch bowl, certain stocks to avoid would come up based on mass layoffs. Effectively, the earlier response to the coronavirus pandemic led to a dramatic rise in the real M2 money stock. However, inflation didn’t become particularly pronounced until people
Are you ready to spin the wheel and take a chance on Bally’s (NYSE:BALY)? Not so fast, as BALY stock could continue to lose value in 2023. A turnaround in macroeconomic conditions would certainly help Bally’s recover from its slump. Yet, the company’s fiscal figures should set off some alarm bells for cautious investors. Don’t get
This week, shares of low-quality meme stocks jumped on renewed retail interest. Struggling chain Bed Bath & Beyond (NASDAQ:BBBY) jumped 240%, while Party City (NYSE:PRTY) would rise 90%. And having followed these stocks for the past several years at InvestorPlace, here’s one thing I’ve learned: People love making tons of money. (And preferably with little
2022 was brutal for electric vehicle (EV) manufacturers, and investors of Lucid Group (NASDAQ:LCID) really got slammed. This, however, opens up the possibility that LCID stock is trading at an attractive price point. It certainly adds interest and intrigue that a sovereign-wealth fund recently added nearly $1 billion to its investment in Lucid Group. That’s
Shares in Quantumscape (NYSE:QS) may have been hit hard by the 2022 stock market downturn, but so far in 2023, QS stock has been on a tear, soaring more than 33.5% since the first trading day of the year. So, is this the start of a comeback for this electric vehicle battery technology play? Not so
Tilray (NASDAQ:TLRY) stock could rise or fall in 2023, based on whether American legislators make progress with pro-cannabis bills. While TLRY is a Canadian company, it sells cannabis-related products throughout North America. Thus, U.S. marijuana laws are highly relevant to Tilray and its stakeholders. So far, this looks like a steep uphill battle, and that’s bad news
There are several reasons why it’s best to steer clear of Alphabet (NASDAQ:GOOG,NASDAQ:GOOGL) shares. Among these various reasons, a key one that could affect the future performance of GOOG stock is rising competition. High competition is having a greater impact on Alphabet’s cloud computing and streaming segments. However, not even its bread-and-butter search advertising segment
Folks who held shares of Rivian Automotive (NASDAQ:RIVN) stock had a rough ride last year. Will 2023 be any better? The outlook is dim, and perhaps a bit grim, as Rivian’s cash position isn’t ideal. Plus, supply chain disruptions could continue to cause problems for the automaker. Frankly, you probably won’t want to load up
While it’s always risky to go against the masses, certain short-squeeze stocks for contrarians to consider may perform surprisingly well. Invariably, even the collective sometimes gets things wrong. Certainly, if everyone bets on the same horse, the subsequent individual reward (if any) would be significantly limited. And that’s part of the reason why going against
In 2022, I was able to greatly reduce my stock portfolio’s losses by shorting several U.S. equities. I found it fairly easy to find favorable stocks to short, as the valuations of many companies were ridiculously high last year, and many stocks were pricing in scenarios that almost certainly would never materialize. For example, I
If you have a love-hate relationship with Mullen Technologies (NASDAQ:MULN), you’re not alone. “Bought at [41 cents] and I know it’s going to crash,” read a post on Reddit last week. “I’m about to get burned I know it.” The electric vehicle penny stock has become a curiosity over the past several months, earning both
Shares in SoFi Technologies (NASDAQ:SOFI) have traded sideways over the past month. This is not surprising, given there have not been too many headlines about SOFI stock, since the short-lived excitement surrounding news of insider buying by CEO Anthony Noto. That said, there is something on the horizon that will likely bring this fintech stock
Nvidia (NASDAQ:NVDA) is sometimes known as the graphics processing unit king or at least a contender for the crown. You’ll even find Nvidia’s products on the go, in self-driving vehicles. Unfortunately, the company’s fiscal stats make it difficult to give NVDA stock anything higher than a “D” rating at the moment. This is a dilemma that
In 2012, Tesla (NASDAQ:TSLA) launched its first mass-production vehicle, the Tesla Model S. Love or hate the firm (or its controversial boss), the vehicle was a stunning leap forward in electric vehicle technology. The car could travel 265 miles on a single charge and earned the 2013 Motor Trend Car of the Year award. Reviewers
For investors in a wide swath of companies, 2022 was a rough year. That said, it was a downright brutal year for those invested in most tech companies. Indeed, the three stocks on this list are among the mega-cap juggernauts of the tech world. With market capitalizations ranging from $335 billion to more than $2
Biotech stocks are in high demand right now, with good reason. Indeed, these biotech companies have the potential to revolutionize the medical world and offer solutions to unmet needs, while their relevance is recession-proof. With growing demand for gene therapies, immune oncology, and precision medicine, biotech companies have a unique opportunity to impact the world
Hardly anyone, including the company’s fans, would call California-based neo-banking firm SoFi Technologies (NASDAQ:SOFI) a winner in 2022. SOFI stock lost a great deal of value that year, but this could be a setup for a multi-bagger recovery. Indeed, at least one Wall Street expert sees a favorable reward-to-risk ratio for SoFi Technologies’ investors. So,
- « Previous Page
- 1
- …
- 55
- 56
- 57
- 58
- 59
- …
- 64
- Next Page »